Skip to content
Governance Register

Company · Abingdon

Summit (Oxford) Limited

Research and experimental development on biotechnology

Official record Companies House · updated 27th September 2026 · Sources

Network

The large node is Summit (Oxford) Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 21

  1. Ankur Dhingra 2022-2024 Director View profile
  2. Campbell Hair 2021-2022 Director View profile
  3. Jeffrey Maranian 2021-2022 Director View profile
  4. Dr David Jonathan Powell 2021-2021 Director View profile
  5. Dr Ventzislav Kirilov Stefanov 2020-2020 Director View profile
  6. Glyn Owain Edwards 2012-2020 Director View profile
  7. Dr Barry John Price 2011-2012 Director View profile
  8. James Christopher Taylor 2006-2008 Director View profile
  9. Dr Richard Storer 2006-2012 Director View profile
  10. Darren Michael Millington 2005-2008 Director View profile
  11. Dr Steven Koon Ching Lee 2003-2010 Director View profile
  12. David Robert Norwood 2003-2008 Director View profile
  13. Professor Stephen Graham Davies 2003-2013 Director View profile
  14. Dr Andrew William Mulvaney 2003-2005 Director View profile
  15. Wcphd Directors Limited 2003-2003 Corporate-director View profile
  16. Hugh Feargal O'Neill 2020-2021 Secretary View profile
  17. Melissa Claire Strange 2016-2020 Secretary View profile
  18. Anthony Weir 2008-2009 Secretary View profile
  19. Sharon Jeen Benning Prince 2008-2008 Secretary View profile
  20. John Alexander Montgomery 2003-2006 Secretary View profile
  21. Wcphd Secretaries Limited 2003-2004 Corporate-secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

What it does
Research and experimental development on biotechnology
Incorporated
14/01/2003
Registered office
Abingdon
Previous names
Vastox Chemical Genomics Limited (until 06/08/2007)

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. Summit (Oxford) Limited is controlled by Summit Therapeutics Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register

Ultimately controlled by Summit Therapeutics Limited.

9 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

3 directors on the board

3.7y median 2.6y
average tenure
6.1y
longest tenure

Directors past 6 years

First-time vs portfolio directors

Portfolio (3)

0
also govern a charity
0
left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Professional services 7

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
04636431
Status
Active
Type
Private Limited Company
Accounts next due
31/12/2026
Edition
Register edition compiled 27th September 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data